| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |